Experimental group:Baratinib

2 trials

Sponsors

Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, the First Affiliated Hospital of Soochow University

Conditions

dermatomyositis

Phase 2

An open-label, randomized controlled trial for baratinib in the treatment of dermatomyositis

RecruitingChiCTR2000030591

Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong Universitydermatomyositis

Start: 2019-12-01Updated: 2020-03-09

Phase 4

Baratinib in the treatment of MDA5+ dermatomyositis with interstitial lung disease: a prospective, multicenter, open-label trial

Active, not recruitingChiCTR2100047938

the First Affiliated Hospital of Soochow Universitydermatomyositis

Start: 2021-07-01Updated: 2022-03-07